Chemotherapy of advanced non small cell lung cancer in the elderly: an update
- 23 August 2000
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 35 (3) , 219-225
- https://doi.org/10.1016/s1040-8428(99)00064-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatinCancer, 1999
- Lung cancer in the elderlyEuropean Journal Of Cancer, 1997
- 82 Treatment of advanced and disseminated non small lung cancer (NSCLC) in elderly patients: Results of the MIC regimenLung Cancer, 1997
- Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyEuropean Journal Of Cancer, 1997
- Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patientsEuropean Journal Of Cancer, 1996
- Age and the treatment of lung cancer.Thorax, 1996
- What do we know on variables influencing clinical decision-making in elderly cancer patients?European Journal Of Cancer, 1996
- Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ FunctionsJapanese Journal of Cancer Research, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderlyJAMA, 1987